These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5773811)

  • 1. Combination chemotherapy: synergistic inhibition of lymphoma L5178Y cells in culture and in vivo with 6-mercaptopurine and 6-(methylmercapto)purine ribonucleoside.
    Paterson AR; Moriwaki A
    Cancer Res; 1969 Mar; 29(3):681-6. PubMed ID: 5773811
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of the growth inhibition potentiation arising from combination of 6-mercaptopurine with 6-(methylmercapto)purine ribonucleoside.
    Paterson AR; Wang MC
    Cancer Res; 1970 Sep; 30(9):2379-87. PubMed ID: 4319905
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy: treatment of the Ehrlich ascites carcinoma and several drug-resistant sublines with combinations of 6-mercaptopurine and 6-(methylmercapto)purine ribonucleoside.
    Paterson AR; Wang MC
    Can J Biochem; 1970 Jan; 48(1):79-83. PubMed ID: 5512546
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical mechanisms for the synergism between 6-thioguanine and 6-(methylmercapto)purine ribonucleoside in sarcoma 180 cells.
    Nelson JA; Parks RE
    Cancer Res; 1972 Oct; 32(10):2034-41. PubMed ID: 4673141
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic effect of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside on the levels of adenine nucleotides of Sarcoma 180 cells.
    Scholar EM; Brown PR; Parks RE
    Cancer Res; 1972 Feb; 32(2):259-69. PubMed ID: 5058187
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of 4-methyluracil on the antineoplastic and toxic effect of 6-mercaptopurine].
    Pol'kina RI
    Vopr Onkol; 1971; 17(1):86. PubMed ID: 5108359
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic action of cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on a transplanted murine lymphoma.
    Valeriote FA; Bruce WR; Meeker BE
    J Natl Cancer Inst; 1968 May; 40(5):935-44. PubMed ID: 5648137
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies with analogues of purine nucleosides.
    LePage GA
    Natl Cancer Inst Monogr; 1971 Dec; 34():184-7. PubMed ID: 5140862
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of antibody production by thioinosine. 3. Studies on antibody biosynthesis.
    Ogata M; Kumashiro K
    Acta Med Okayama (1952); 1970 Jun; 24(3):311-4. PubMed ID: 4249887
    [No Abstract]   [Full Text] [Related]  

  • 10. Interference with nucleoside transport in mouse lymphoma cells proliferating in culture.
    Warnick CT; Muzik H; Paterson AR
    Cancer Res; 1972 Oct; 32(10):2017-22. PubMed ID: 4673140
    [No Abstract]   [Full Text] [Related]  

  • 11. Amplification of the cytotoxin action of glucocorticoid in cultured L5178y lymphoblasts.
    Kido H; Nakanishi T; Katunuma N
    Cancer Res; 1978 Sep; 38(9):3100-3. PubMed ID: 354783
    [No Abstract]   [Full Text] [Related]  

  • 12. A delayed cytotoxic reaction for 6-mercaptopurine.
    Tidd DM; Kim SC; Horakova K; Moriwaki A; Paterson AR
    Cancer Res; 1972 Feb; 32(2):317-22. PubMed ID: 5058188
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxicity and the effect of combined treatment with X-rays of an anticancer 1-nitro-9-aminoacridine derivative in L5178Y-R and L5178Y-S cells.
    Szumiel I; Walicka M
    Neoplasma; 1980; 27(6):697-702. PubMed ID: 7254425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of 6-mercaptopurine (NSC-755) and 6-(methylmercapto)purine ribonucleoside (NSC-40774) in therapy of Ehrlich ascites carcinoma.
    Wang MC; Simpson AI; Paterson AR
    Cancer Chemother Rep; 1967 Jun; 51(3):101-9. PubMed ID: 6043733
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased feedback inhibition in a 6-(methylmercapto)purine ribonucleoside-resistant tumor.
    Henderson JF; Caldwell IC; Paterson AR
    Cancer Res; 1967 Oct; 27(10):1773-8. PubMed ID: 6064956
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide-induced tumour regression of cyclophosphamide-resistant L5178Y lymphoma through suppressor cells elimination.
    Andrade-Mena CE
    Int J Tissue React; 1994; 16(2):95-103. PubMed ID: 7960506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo.
    Zhang L; Qian Z; Cai Z; Sun L; Wang H; Bartlett JB; Yi Q; Wang M
    Am J Hematol; 2009 Sep; 84(9):553-9. PubMed ID: 19565649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine.
    Danysz A; Wierzba K; Wutkiewicz M; Pniewska A; Pragłowski T; Burba-Anczewska I
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):345-9. PubMed ID: 6395826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.
    Bruce WR; Meeker BE; Valeriote FA
    J Natl Cancer Inst; 1966 Aug; 37(2):233-45. PubMed ID: 5912615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.